ACRV
Acrivon Therapeutics, Inc. - Common Stock (ACRV)
$81
About Acrivon Therapeutics, Inc. - Common Stock (ACRV)
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.
Details
Daily high
$1.87
Daily low
$1.66
Price at open
$1.85
52 Week High
$10.77
52 Week Low
$1.30
Market cap
56.7M
Dividend yield
0.00%
Volume
236,493
Avg. volume
412,590
P/E ratio
-.74
Acrivon Therapeutics, Inc. - Common Stock News
Details
Daily high
$1.87
Daily low
$1.66
Price at open
$1.85
52 Week High
$10.77
52 Week Low
$1.30
Market cap
56.7M
Dividend yield
0.00%
Volume
236,493
Avg. volume
412,590
P/E ratio
-.74